-
1
-
-
0031975435
-
The haematological manifestations of sepsis
-
Mammen EF. The haematological manifestations of sepsis. J Antimicrobial Chemotherapy 1998;41(Suppl A):17-24.
-
(1998)
J Antimicrobial Chemotherapy
, vol.41
, Issue.SUPPL. A
, pp. 17-24
-
-
Mammen, E.F.1
-
2
-
-
0034278977
-
Disseminated intravascular coagulation
-
Mammen EF. Disseminated intravascular coagulation. Clin Lab Sci 2000;13:239-45.
-
(2000)
Clin Lab Sci
, vol.13
, pp. 239-245
-
-
Mammen, E.F.1
-
3
-
-
0035216914
-
Advances in the understanding of the pathogenic pathways of disseminated intravascular coagulation results in more insight in the clinical picture and better management strategies
-
Levit M, de Jong E, van der Poll T, ten Cate H. Advances in the understanding of the pathogenic pathways of disseminated intravascular coagulation results in more insight in the clinical picture and better management strategies. Semin Thromb Hemost 2001;27:569-76.
-
(2001)
Semin Thromb Hemost
, vol.27
, pp. 569-576
-
-
Levit, M.1
De Jong, E.2
Van Der Poll, T.3
Ten Cate, H.4
-
4
-
-
0035216945
-
Laboratory testing in disseminated intravascular coagulation
-
Toh CH. Laboratory testing in disseminated intravascular coagulation. Semin Thromb Hemost 2001;27:653-6.
-
(2001)
Semin Thromb Hemost
, vol.27
, pp. 653-656
-
-
Toh, C.H.1
-
5
-
-
0027265855
-
Coagulation disorders in septic shock
-
Thijs LG, de Boer JP, de Groot M, Hack CE. Coagulation disorders in septic shock. Intensive Care Med 1993;19(Suppl 1):8-15.
-
(1993)
Intensive Care Med
, vol.19
, Issue.SUPPL. 1
, pp. 8-15
-
-
Thijs, L.G.1
De Boer, J.P.2
De Groot, M.3
Hack, C.E.4
-
6
-
-
0033584457
-
Disseminated intravascular coagulation
-
Levi M, ten Cate H. Disseminated intravascular coagulation. N Engl J Med 1999;341:586-92.
-
(1999)
N Engl J Med
, vol.341
, pp. 586-592
-
-
Levi, M.1
Ten Cate, H.2
-
7
-
-
0035217849
-
Fibrin degradation products, fibrin monomer and soluble fibrin in disseminated intravascular coagulation
-
Horan JT, Francis CW. Fibrin degradation products, fibrin monomer and soluble fibrin in disseminated intravascular coagulation. Semin Thromb Hemost 2001;27:657-66.
-
(2001)
Semin Thromb Hemost
, vol.27
, pp. 657-666
-
-
Horan, J.T.1
Francis, C.W.2
-
8
-
-
0035216815
-
Fibrinolysis in disseminated intravascular coagulation
-
Hack CE. Fibrinolysis in disseminated intravascular coagulation. Semin Thromb Hemost 2001;27:633-8.
-
(2001)
Semin Thromb Hemost
, vol.27
, pp. 633-638
-
-
Hack, C.E.1
-
9
-
-
0032697618
-
Biochemistry and physiology of blood coagulation
-
Mann KG. Biochemistry and physiology of blood coagulation. Thromb Haemost 1999;82:165-74.
-
(1999)
Thromb Haemost
, vol.82
, pp. 165-174
-
-
Mann, K.G.1
-
10
-
-
18044385747
-
The tissue factor pathway in disseminated intravascular coagulation
-
Osterud B, Bjorklid E. The tissue factor pathway in disseminated intravascular coagulation. Semin Thromb Hemost 2001;27:605-17.
-
(2001)
Semin Thromb Hemost
, vol.27
, pp. 605-617
-
-
Osterud, B.1
Bjorklid, E.2
-
11
-
-
0016790233
-
The endotoxin-induced coagulant activity of human monocytes
-
Rivers RP, Hathaway WE, Weston WI. The endotoxin-induced coagulant activity of human monocytes. Br J Haematol 1975;30:311-6.
-
(1975)
Br J Haematol
, vol.30
, pp. 311-316
-
-
Rivers, R.P.1
Hathaway, W.E.2
Weston, W.I.3
-
12
-
-
0035217872
-
Regulatory role of cytokines in disseminated intravascular coagulation
-
van der Poll T, de Jong E, Levi M. Regulatory role of cytokines in disseminated intravascular coagulation. Semin Thromb Hemost 2001;27:639-51.
-
(2001)
Semin Thromb Hemost
, vol.27
, pp. 639-651
-
-
Van Der Poll, T.1
De Jong, E.2
Levi, M.3
-
13
-
-
0024991650
-
Regulation of coagulation by a multivalent Kunitz-type inhibitor
-
Broze GJ Jr, Warren LA, Novotny WF. Regulation of coagulation by a multivalent Kunitz-type inhibitor. Biochemistry 1990;29:7539-44.
-
(1990)
Biochemistry
, vol.29
, pp. 7539-7544
-
-
Broze G.J., Jr.1
Warren, L.A.2
Novotny, W.F.3
-
14
-
-
0002425830
-
Regulation of blood coagulation by protease inhibitors
-
In: Stamatoyannopoulos G, Nienhuis AW, Majerus PW, Varmus H (eds); Philadelphia: Saunders
-
Broze GJ Jr, Tollefsen DM. Regulation of blood coagulation by protease inhibitors. In: Stamatoyannopoulos G, Nienhuis AW, Majerus PW, Varmus H (eds). The Molecular Basis of Blood Disorders. 2nd ed. Philadelphia: Saunders, 1994:629-56.
-
(1994)
The Molecular Basis of Blood Disorders. 2nd ed
, pp. 629-656
-
-
Broze G.J., Jr.1
Tollefsen, D.M.2
-
15
-
-
0029039574
-
Tissue factor pathway inhibitor and the current concept of blood coagulation
-
Broze GJ Jr. Tissue factor pathway inhibitor and the current concept of blood coagulation. Blood Coagul Fibrinolysis 1995;1:7-13.
-
(1995)
Blood Coagul Fibrinolysis
, vol.1
, pp. 7-13
-
-
Broze G.J., Jr.1
-
16
-
-
0031906776
-
Antithrombin: Its physiological importance and role in DIC
-
Mammen EF. Antithrombin: Its physiological importance and role in DIC. Semin Thromb Hemost 1998;24:19-25.
-
(1998)
Semin Thromb Hemost
, vol.24
, pp. 19-25
-
-
Mammen, E.F.1
-
17
-
-
0019163952
-
The kinetics of hemostatic enzyme-antithrombin interactions in the presence of low molecular weight heparin
-
Jordan RE, Oosta GM, Gardner WT, Rosenberg RD. The kinetics of hemostatic enzyme-antithrombin interactions in the presence of low molecular weight heparin. J Biol Chem 1980;255:10081-96.
-
(1980)
J Biol Chem
, vol.255
, pp. 10081-10096
-
-
Jordan, R.E.1
Oosta, G.M.2
Gardner, W.T.3
Rosenberg, R.D.4
-
18
-
-
0029593690
-
Clinical relevance of antithrombin deficiencies
-
Mammen EF. Clinical relevance of antithrombin deficiencies. Semin Hematol 1995;32(Suppl 2):2-6.
-
(1995)
Semin Hematol
, vol.32
, Issue.SUPPL. 2
, pp. 2-6
-
-
Mammen, E.F.1
-
19
-
-
0029981299
-
Antithrombin levels related to infections and outcome
-
Wilson RF, Mammen EF, Tyburski JG, Warsow KM, Kubinec SM. Antithrombin levels related to infections and outcome. J Trauma 1996;40:384-7.
-
(1996)
J Trauma
, vol.40
, pp. 384-387
-
-
Wilson, R.F.1
Mammen, E.F.2
Tyburski, J.G.3
Warsow, K.M.4
Kubinec, S.M.5
-
20
-
-
0025807728
-
DEGR-factor Xa blocks disseminated intravascular coagulation initiated by Escherichia coli without preventing shock and organ damage
-
Taylor FB Jr, Chang ACK, Peer GT, et al. DEGR-factor Xa blocks disseminated intravascular coagulation initiated by Escherichia coli without preventing shock and organ damage. Blood 1991;78:364-8.
-
(1991)
Blood
, vol.78
, pp. 364-368
-
-
Taylor F.B., Jr.1
Chang, A.C.K.2
Peer, G.T.3
-
21
-
-
0024343069
-
Antithrombin III stimulates prostacyclin production by cultured aortic endothelial cells
-
Yamanuchi T, Umeda F, Inoguchi I, Nawata H. Antithrombin III stimulates prostacyclin production by cultured aortic endothelial cells. Biochem Biophys Res Commun 1989;163:1404-11.
-
(1989)
Biochem Biophys Res Commun
, vol.163
, pp. 1404-1411
-
-
Yamanuchi, T.1
Umeda, F.2
Inoguchi, I.3
Nawata, H.4
-
22
-
-
0031930384
-
The antiinflammatory properties of antithrombin III: New therapeutic implications
-
Okajima K, Uchiba M. The antiinflammatory properties of antithrombin III: New therapeutic implications. Semin Thromb Hemost 1998;24:27-32.
-
(1998)
Semin Thromb Hemost
, vol.24
, pp. 27-32
-
-
Okajima, K.1
Uchiba, M.2
-
23
-
-
0029587161
-
Influence of high-dose antithrombin concentrate therapy on the release of cellular proteinases, cytokines, and soluble adhesion molecules in acute inflammation
-
Jochum M. Influence of high-dose antithrombin concentrate therapy on the release of cellular proteinases, cytokines, and soluble adhesion molecules in acute inflammation. Semin Hematol 1995;32(Suppl 2):19-32.
-
(1995)
Semin Hematol
, vol.32
, Issue.SUPPL. 2
, pp. 19-32
-
-
Jochum, M.1
-
24
-
-
0033859376
-
Antithrombin reduces leukocyte adhesion during chronic endotoxemia by modulation of the cyclooxygenase pathway
-
Hoffmann JN, Vollmar B, Inthorn D, Schildberg FW, Menger MD. Antithrombin reduces leukocyte adhesion during chronic endotoxemia by modulation of the cyclooxygenase pathway. Am J Physiol (Cell Physiol) 2000;279:98-107.
-
(2000)
Am J Physiol (Cell Physiol)
, vol.279
, pp. 98-107
-
-
Hoffmann, J.N.1
Vollmar, B.2
Inthorn, D.3
Schildberg, F.W.4
Menger, M.D.5
-
25
-
-
0035293659
-
Antithrombin reduces mesenteric vascular leukocyte interactions and small intestine injury in endotoxemis rats
-
Neviere R, Tournoys A, Mordon S, et al. Antithrombin reduces mesenteric vascular leukocyte interactions and small intestine injury in endotoxemis rats. Shock 2001;15:220-5.
-
(2001)
Shock
, vol.15
, pp. 220-225
-
-
Neviere, R.1
Tournoys, A.2
Mordon, S.3
-
26
-
-
0029781690
-
Attenuation of endotoxin-induced pulmonary vascular injury by antithrombin
-
Uchiba M, Okajima K, Murakami K, Okabe H, Takatsuki K. Attenuation of endotoxin-induced pulmonary vascular injury by antithrombin. Am J Physiol 1996; 270:921-30.
-
(1996)
Am J Physiol
, vol.270
, pp. 921-930
-
-
Uchiba, M.1
Okajima, K.2
Murakami, K.3
Okabe, H.4
Takatsuki, K.5
-
27
-
-
0031894499
-
Therapeutic use of antithrombin concentrates in sepsis
-
Mammen EF, Balk R, Emerson T Jr, et al. Therapeutic use of antithrombin concentrates in sepsis. Semin Thromb Hemost 1998;24:183-94.
-
(1998)
Semin Thromb Hemost
, vol.24
, pp. 183-194
-
-
Mammen, E.F.1
Balk, R.2
Emerson T., Jr.3
-
28
-
-
0031950793
-
Antithrombin III in animal models of sepsis and organ failure
-
Dickneite G. Antithrombin III in animal models of sepsis and organ failure. Semin Thromb Hemost 1998;24:61-9.
-
(1998)
Semin Thromb Hemost
, vol.24
, pp. 61-69
-
-
Dickneite, G.1
-
29
-
-
0031881384
-
Clinical experience with antithrombin III concentrates in critically ill patients with sepsis and multiple organ failure
-
Eisele B, Lamy M. Clinical experience with antithrombin III concentrates in critically ill patients with sepsis and multiple organ failure. Semin Thromb Hemost 1998;24:71-80.
-
(1998)
Semin Thromb Hemost
, vol.24
, pp. 71-80
-
-
Eisele, B.1
Lamy, M.2
-
31
-
-
0031804584
-
Current drug treatment strategies for disseminated intravascular coagulation
-
de Jong E, Levi M, Stoutenbeek CP, van Deventer SJH. Current drug treatment strategies for disseminated intravascular coagulation. Drugs 1998;55: 767-77.
-
(1998)
Drugs
, vol.55
, pp. 767-777
-
-
De Jong, E.1
Levi, M.2
Stoutenbeek, C.P.3
Van Deventer, S.J.H.4
-
32
-
-
0035904368
-
High-dose antithrombin III in severe sepsis. A randomized controlled trial
-
Warren BL, Eid A, Singer P, et al. High-dose antithrombin III in severe sepsis. A randomized controlled trial. JAMA 2001;286:1869-78.
-
(2001)
JAMA
, vol.286
, pp. 1869-1878
-
-
Warren, B.L.1
Eid, A.2
Singer, P.3
-
33
-
-
84965393931
-
Antithrombin III in shock and disseminated intravascular coagulation
-
Vinazzer HA. Antithrombin III in shock and disseminated intravascular coagulation. Clin Appl Thromb Hemost 1995;1:62-5.
-
(1995)
Clin Appl Thromb Hemost
, vol.1
, pp. 62-65
-
-
Vinazzer, H.A.1
-
34
-
-
0001976355
-
The protein C anticoagulant system
-
In: Stamatoyannapoulos G, Nienhuis AW, Majerus PW, Varmus H (eds); Philadelphia: Saunders
-
Dahlbäck B, Stenflo J. The protein C anticoagulant system. In: Stamatoyannapoulos G, Nienhuis AW, Majerus PW, Varmus H (eds). The Molecular Basis of Blood Diseases. 2nd ed. Philadelphia: Saunders, 1994:599-628.
-
(1994)
The Molecular Basis of Blood Diseases. 2nd ed
, pp. 599-628
-
-
Dahlbäck, B.1
Stenflo, J.2
-
35
-
-
0002690104
-
Protein C, protein S, and thrombomodulin
-
In: Colman RW, Hirsh J, Marder VJ, Clowes AW, George JN (eds); Philadelphia. Lippincott Williams and Wilkins
-
Esmon CT. Protein C, protein S, and thrombomodulin. In: Colman RW, Hirsh J, Marder VJ, Clowes AW, George JN (eds). Hemostasis and Thrombosis. Basic Principles and Clinical Practice. 4th ed. Philadelphia. Lippincott Williams and Wilkins, 2001:335-54.
-
(2001)
Hemostasis and Thrombosis. Basic Principles and Clinical Practice. 4th ed
, pp. 335-354
-
-
Esmon, C.T.1
-
36
-
-
0002695076
-
Hereditary and acquired thrombophilic syndromes
-
In: Colman RW, Hirsh J, Marder VJ, Clowes AW, George JN (eds); Philadelphia: Lippincott Williams and Wilkins
-
Marder VJ, Matei DA. Hereditary and acquired thrombophilic syndromes. In: Colman RW, Hirsh J, Marder VJ, Clowes AW, George JN (eds). Hemostasis and Thrombosis. Basic Principles and Clinical Practice. 4th ed. Philadelphia: Lippincott Williams and Wilkins, 2001:1243-75.
-
(2001)
Hemostasis and Thrombosis. Basic Principles and Clinical Practice. 4th ed
, pp. 1243-1275
-
-
Marder, V.J.1
Matei, D.A.2
-
37
-
-
0026061609
-
Protein C, protein S and C4b-binding protein in severe infection and septic shock
-
Hesselvik JF, Malm J, Dahlbäck B, et al. Protein C, protein S and C4b-binding protein in severe infection and septic shock. Thromb Haemost 1991; 65:126-9.
-
(1991)
Thromb Haemost
, vol.65
, pp. 126-129
-
-
Hesselvik, J.F.1
Malm, J.2
Dahlbäck, B.3
-
38
-
-
0022601049
-
Modulation of endothelial cell hemostasis properties by tumor necrosis factor
-
Nawroth PP, Stern DM. Modulation of endothelial cell hemostasis properties by tumor necrosis factor. J Exp Med 1986;163:740-5.
-
(1986)
J Exp Med
, vol.163
, pp. 740-745
-
-
Nawroth, P.P.1
Stern, D.M.2
-
39
-
-
0027943163
-
Identification, cloning and regulation of a novel endothelial cell protein C/activated protein C receptor
-
Fukudome K, Esmon CT. Identification, cloning and regulation of a novel endothelial cell protein C/activated protein C receptor. J Biol Chem 1994;269: 26486-91.
-
(1994)
J Biol Chem
, vol.269
, pp. 26486-26491
-
-
Fukudome, K.1
Esmon, C.T.2
-
40
-
-
0030034186
-
Activated protein C attenuates endotoxin induced pulmonary vascular injury by inhibiting activated leukocytes in rats
-
Murakami K, Okajima K, Uchiba M, et al. Activated protein C attenuates endotoxin induced pulmonary vascular injury by inhibiting activated leukocytes in rats. Blood 1996;87:642-7.
-
(1996)
Blood
, vol.87
, pp. 642-647
-
-
Murakami, K.1
Okajima, K.2
Uchiba, M.3
-
41
-
-
0023122016
-
Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon
-
Taylor FB Jr, Chang A, Esmon CT, et al. Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon. J Clin Invest 1987;70:918-25.
-
(1987)
J Clin Invest
, vol.70
, pp. 918-925
-
-
Taylor F.B., Jr.1
Chang, A.2
Esmon, C.T.3
-
42
-
-
0027993226
-
Characteristic effects of activated protein C on tissue thromboplastin-induced disseminated intravascular coagulation in rabbits
-
Katsura Y, Aoki K, Tanabe H, et al. Characteristic effects of activated protein C on tissue thromboplastin-induced disseminated intravascular coagulation in rabbits. Thromb Res 1994;76:353-62.
-
(1994)
Thromb Res
, vol.76
, pp. 353-362
-
-
Katsura, Y.1
Aoki, K.2
Tanabe, H.3
-
43
-
-
0035826096
-
Efficacy and safety of recombinant activated human protein C for severe sepsis
-
Bernhard GR, Vincent JL, Laterre PF, et al. Efficacy and safety of recombinant activated human protein C for severe sepsis. N Engl J Med 2001;344: 699-709.
-
(2001)
N Engl J Med
, vol.344
, pp. 699-709
-
-
Bernhard, G.R.1
Vincent, J.L.2
Laterre, P.F.3
-
44
-
-
0033590515
-
Treating patients with severe sepsis
-
Wheeler AP, Bernhard GR. Treating patients with severe sepsis. N Engl J Med 1999;340:207-14.
-
(1999)
N Engl J Med
, vol.340
, pp. 207-214
-
-
Wheeler, A.P.1
Bernhard, G.R.2
-
45
-
-
0029092928
-
Sepsis trials, intersection of investigation, regulation, funding, and practice
-
Bernard GR. Sepsis trials, intersection of investigation, regulation, funding, and practice. Am J Resp Crit Care Med 1995;152:4-10.
-
(1995)
Am J Resp Crit Care Med
, vol.152
, pp. 4-10
-
-
Bernard, G.R.1
-
46
-
-
0026048714
-
The pathogenesis of sepsis
-
Bone CR. The pathogenesis of sepsis. Ann Intern Med 1991;115:457-69.
-
(1991)
Ann Intern Med
, vol.115
, pp. 457-469
-
-
Bone, C.R.1
-
47
-
-
0035904322
-
Continuing challenges of sepsis research
-
Crowther MA, Marshall JC. Continuing challenges of sepsis research. JAMA 2001;286:1894-6.
-
(2001)
JAMA
, vol.286
, pp. 1894-1896
-
-
Crowther, M.A.1
Marshall, J.C.2
|